• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经功能缺损严重程度与发病后最初几小时的最终功能结局的关系发生改变和增强。

Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset.

机构信息

Stroke Center and Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

出版信息

Stroke. 2012 Jun;43(6):1537-41. doi: 10.1161/STROKEAHA.111.636928. Epub 2012 Apr 5.

DOI:10.1161/STROKEAHA.111.636928
PMID:22492517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3509751/
Abstract

BACKGROUND AND PURPOSE

Early neurological deficit severity is the most important determinant of final functional outcome in acute ischemic stroke. However, deficit severity frequently changes during the first hours and days postonset.

METHODS

Analysis of control group patients enrolled in the 2 National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Neurological deficit severity was measured serially using the National Institutes of Health Stroke Scale (NIHSS) at 1 to 3 hours postonset, 3 to 5 hours, 24 hours, 7 to 10 days, and 90 days. Final global disability outcome was assessed at 90 days using the modified Rankin Scale.

RESULTS

Among the 312 patients, median neurological deficit severity on the NIHSS improved throughout the 90-day observation period, from 15 (interquartile range, 9.5-20) at 1 to 3 hours, to 12 (interquartile range, 6-19) at 24 hours, to 7 (interquartile range, 2-19) at 90 days. Between 1-to-3-hours to 24 hours, more patients spontaneously improved than worsened: 39.1% versus 17.6% (P<0.001). NIHSS scores associated with individual final modified Rankin Scale global disability ranks shifted to lower values over time; eg, patients with a final modified Rankin Scale of 2 had the following median NIHSS scores: 12 at 1 to 3 hours, 10 at 3 to 5 hours, 9 at 24 hours, and 3 at 90 days. Correlation coefficients between NIHSS and the final modified Rankin Scale increased over time, from 0.51 at 1 to 3 hours, to 0.72 at 24 hours, to 0.87 at 90 days.

CONCLUSIONS

During the first 24 hours after onset, spontaneous improvement occurs in 2 of 5 acute ischemic stroke patients. The NIHSS scores associated with individual global disability ranks decrease over time. Neurological deficit severity increasingly predicts final disability outcome, accounting for one quarter of the variance at 1 to 3 hours, one half at 24 hours, and three quarters at 90 days.

摘要

背景与目的

急性缺血性脑卒中发病后最初数小时至数天内,神经功能缺损严重程度是决定最终功能结局的最重要因素。然而,发病后最初数小时至数天内,神经功能缺损严重程度常常发生变化。

方法

对 2 项美国国立卫生研究院卒中量表(NIHSS)组织型纤溶酶原激活物溶栓临床试验的对照组患者进行分析。发病后 1 至 3 小时、3 至 5 小时、24 小时、7 至 10 天和 90 天,使用 NIHSS 连续测量神经功能缺损严重程度。发病 90 天,采用改良 Rankin 量表评估最终总体残疾结局。

结果

312 例患者中,发病 90 天内 NIHSS 中位数逐渐改善,从发病后 1 至 3 小时的 15(四分位间距 9.5-20),到 24 小时的 12(四分位间距 6-19),到 90 天的 7(四分位间距 2-19)。发病后 1 至 3 小时至 24 小时,自发改善患者多于恶化患者:39.1%比 17.6%(P<0.001)。随着时间推移,与个体最终改良 Rankin 量表总体残疾等级相关的 NIHSS 评分向较低值转移;例如,最终改良 Rankin 量表为 2 分的患者 NIHSS 评分中位数如下:发病后 1 至 3 小时为 12,发病后 3 至 5 小时为 10,发病后 24 小时为 9,发病后 90 天为 3。发病后 1 至 3 小时至 90 天,NIHSS 与最终改良 Rankin 量表之间的相关系数逐渐增加,从 0.51 增加至 0.72,再增加至 0.87。

结论

发病后最初 24 小时内,2/5 的急性缺血性脑卒中患者自发改善。与个体总体残疾等级相关的 NIHSS 评分随时间推移逐渐降低。神经功能缺损严重程度逐渐预测最终残疾结局,在发病后 1 至 3 小时占方差的四分之一,发病后 24 小时占一半,发病后 90 天占四分之三。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d862/3509751/3b548152b535/nihms-369071-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d862/3509751/b287ed4d656e/nihms-369071-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d862/3509751/3b548152b535/nihms-369071-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d862/3509751/b287ed4d656e/nihms-369071-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d862/3509751/3b548152b535/nihms-369071-f0002.jpg

相似文献

1
Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset.神经功能缺损严重程度与发病后最初几小时的最终功能结局的关系发生改变和增强。
Stroke. 2012 Jun;43(6):1537-41. doi: 10.1161/STROKEAHA.111.636928. Epub 2012 Apr 5.
2
Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?对于脑卒中患者的轻度缺陷,是否有理由使用静脉注射组织型纤溶酶原激活剂?
J Stroke Cerebrovasc Dis. 2010 Mar;19(2):116-20. doi: 10.1016/j.jstrokecerebrovasdis.2009.03.019.
3
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.急性缺血性脑卒中伴轻度非致残性神经功能缺损患者阿替普酶与阿司匹林治疗对功能结局的影响:PRISMS 随机临床试验。
JAMA. 2018 Jul 10;320(2):156-166. doi: 10.1001/jama.2018.8496.
4
NXY-059 for acute ischemic stroke.NXY - 059用于急性缺血性卒中。
N Engl J Med. 2006 Feb 9;354(6):588-600. doi: 10.1056/NEJMoa052980.
5
Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.对于症状轻微的缺血性脑卒中患者,不应因其美国国立卫生研究院卒中量表评分低而排除其接受静脉注射组织型纤溶酶原激活物治疗。
J Stroke Cerebrovasc Dis. 2013 May;22(4):550-3. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.021. Epub 2013 Feb 21.
6
Temporal profile of body temperature in acute ischemic stroke: relation to stroke severity and outcome.急性缺血性脑卒中患者体温的时间分布特征:与卒中严重程度及转归的关系。
BMC Neurol. 2012 Oct 18;12:123. doi: 10.1186/1471-2377-12-123.
7
Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.基于国立卫生研究院卒中量表评分的早期神经功能改善可预测接受静脉重组组织型纤溶酶原激活剂治疗后 30 分钟内的良好预后。
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):69-74. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.013. Epub 2012 Nov 16.
8
Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.失语症预测轻度缺血性中风患者的不良预后,并促使溶栓治疗。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):204-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.018. Epub 2013 Jan 24.
9
Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.急性缺血性卒中静脉注射组织型纤溶酶原激活剂的基线国立卫生研究院卒中量表调整时间窗。
Stroke. 2014 Apr;45(4):1059-63. doi: 10.1161/STROKEAHA.113.004307. Epub 2014 Mar 6.
10
Does symptom onset to primary stroke center time goals affect stroke outcome?症状发作至初级卒中中心时间目标是否影响卒中结局?
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):993-1000. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.015. Epub 2013 Oct 6.

引用本文的文献

1
Comparing Early National Institutes of Health Stroke Scale Versus 90-Day Modified Rankin Scale Outcomes in Acute Ischemic Stroke Trials: A Systematic Review and Analysis.急性缺血性卒中试验中早期国立卫生研究院卒中量表与90天改良Rankin量表结果的比较:一项系统评价与分析
J Am Heart Assoc. 2025 May 6;14(9):e040304. doi: 10.1161/JAHA.124.040304. Epub 2025 Apr 25.
2
The paradoxical relationship of sensorimotor deficit and lesion volume in acute ischemic stroke.急性缺血性卒中中感觉运动功能缺损与病灶体积之间的矛盾关系。
J Neuropathol Exp Neurol. 2025 Sep 1;84(9):771-779. doi: 10.1093/jnen/nlaf046.
3
Late neurological improvement during hospitalization is a predicative factor for acute ischemic stroke.

本文引用的文献

1
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.基于 Get With The Guidelines-Stroke 项目推导和验证的院内缺血性卒中死亡率风险评分。
Circulation. 2010 Oct 12;122(15):1496-504. doi: 10.1161/CIRCULATIONAHA.109.932822. Epub 2010 Sep 27.
2
Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit.对两项美国国立神经疾病与中风研究所组织型纤溶酶原激活剂(NINDS-tPA)试验的图表重新分析证实了显著的治疗益处。
Stroke. 2010 Oct;41(10):2381-90. doi: 10.1161/STROKEAHA.110.583807. Epub 2010 Sep 9.
3
A method to determine stroke trial success using multidimensional pooled control functions.
住院期间晚期神经功能改善是急性缺血性卒中的一个预测因素。
Eur J Med Res. 2025 Apr 24;30(1):324. doi: 10.1186/s40001-025-02469-8.
4
Epigenetic Clock Analysis for National Institutes of Health Stroke Scale in Patients With Ischemic Stroke.缺血性中风患者美国国立卫生研究院卒中量表的表观遗传时钟分析
Neuropsychopharmacol Rep. 2025 Mar;45(1):e70009. doi: 10.1002/npr2.70009.
5
Efficacy and safety of very early rehabilitation for acute ischemic stroke: a systematic review and meta-analysis.急性缺血性卒中极早期康复的疗效与安全性:一项系统评价与Meta分析
Front Neurol. 2024 Oct 22;15:1423517. doi: 10.3389/fneur.2024.1423517. eCollection 2024.
6
Early antiplatelet therapy after intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis.急性缺血性卒中静脉溶栓后早期抗血小板治疗:一项系统评价和荟萃分析。
Neurol Sci. 2025 Feb;46(2):617-631. doi: 10.1007/s10072-024-07821-0. Epub 2024 Oct 29.
7
Factors Influencing the Association of 24-hour National Institutes of Health Stroke Scale & 90-day Modified Rankin Score.影响24小时美国国立卫生研究院卒中量表与90天改良Rankin量表相关性的因素。
Clin Neuroradiol. 2025 Mar;35(1):141-150. doi: 10.1007/s00062-024-01459-3. Epub 2024 Oct 15.
8
ASTRAL scale for predicting prognosis following intravenous thrombolysis with anterior versus posterior circulation acute ischemic stroke.用于预测前循环与后循环急性缺血性脑卒中静脉溶栓后预后的ASTRAL量表。
J Thromb Thrombolysis. 2025 Feb;58(2):254-259. doi: 10.1007/s11239-024-03049-z. Epub 2024 Oct 5.
9
Combining Quantitative Susceptibility Mapping With the Gray Matter Volume to Predict Neurological Deficits in Patients With Small Artery Occlusion.联合定量磁敏感图与灰质体积预测小血管闭塞患者的神经功能缺损。
Brain Behav. 2024 Oct;14(10):e70080. doi: 10.1002/brb3.70080.
10
Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study.二十四小时溶栓后 NIHSS 评分是急性缺血性脑卒中后最强的预后预测指标:ENCHANTED 研究。
J Am Heart Assoc. 2024 Sep 17;13(18):e036109. doi: 10.1161/JAHA.124.036109. Epub 2024 Sep 11.
一种使用多维合并控制函数来确定中风试验成功与否的方法。
Stroke. 2009 May;40(5):1803-10. doi: 10.1161/STROKEAHA.108.532820. Epub 2009 Mar 12.
4
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials.预测急性缺血性卒中后的长期预后:一个简单指标对来自对照临床试验的患者有效。
Stroke. 2008 Jun;39(6):1821-6. doi: 10.1161/STROKEAHA.107.505867. Epub 2008 Apr 10.
5
Neural correlates of motor recovery after stroke: a longitudinal fMRI study.中风后运动恢复的神经关联:一项纵向功能磁共振成像研究
Brain. 2003 Nov;126(Pt 11):2476-96. doi: 10.1093/brain/awg245. Epub 2003 Aug 22.
6
Serial assessment of acute stroke using the NIH Stroke Scale.使用美国国立卫生研究院卒中量表对急性卒中进行连续评估。
Stroke. 1994 Feb;25(2):362-5. doi: 10.1161/01.str.25.2.362.
7
Tissue plasminogen activator for acute ischemic stroke.用于急性缺血性卒中的组织型纤溶酶原激活剂
N Engl J Med. 1995 Dec 14;333(24):1581-7. doi: 10.1056/NEJM199512143332401.
8
Spontaneous improvement after acute ischemic stroke. A pilot study.急性缺血性中风后的自发改善。一项试点研究。
Stroke. 1990 Jul;21(7):1008-12. doi: 10.1161/01.str.21.7.1008.